MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Physical activity and incidence of Parkinson’s disease in French women from the E3N cohort study

    B. Portugal, F. Artaud, I. Degaey, E. Roze, G. Severi, M. Canonico, C. Proust-Lima, A. Elbaz (Villejuif, France)

    Objective: To examine the association between time-dependent physical activity (PA) and incidence of Parkinson’s disease (PD) in women from the E3N cohort over 29 years…
  • 2022 International Congress

    Spinocerebellar Ataxia Type 5: an Unusual Infantile Onset with Development Delay

    S. Gallo, L. Magistrelli, E. Contaldi, I C. Campini, R. Cantello, C. Comi (Novara, Italy)

    Objective: Spinocerebellar Ataxia Type 5 (SCA5) is an uncommon cause of cerebellar ataxia with onset generally within the third and the fourth decade and a…
  • 2022 International Congress

    Cognitive and Psychiatric Correlates of Fear of Falling in Progressive Supranuclear Palsy and Multiple System Atrophy

    V. Martinez-Villota, C. Terroba-Chambi Chambi, S. Castillo-Torres, M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the clinical correlates of fear of falling (FoF) in patients with Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA) Background: FoF…
  • 2022 International Congress

    LRRK2 and GBA major variants in the New York Mount Sinai BioMe Biobank

    A. Yoo, R. Ortega, V. Katsnelson, A. Debebe, A. Rendon, M. Picker, D. Raymond, S. Bressman, L. Ozelius, I. Peter, R. Saunders-Pullman (New York, USA)

    Objective: To characterize the frequency of major LRRK2 and GBA variants in a multi-ethnic New York cohort with and without Parkinson disease (PD). Background: There…
  • 2022 International Congress

    Longitudinal Assessessment of Social Cognition in de novo PD patients and its Relationship with Striatal Dopaminergic Innervation

    C. Trompeta, C. Gasca-Salas, JA. Pineda Pardo, P. Guida, D. Mata-Marín, M. Hg Monje, A. Sánchez-Ferro, I. Obeso, JA. Obeso (Móstoles, Spain)

    Objective: To prospectively assess social cognition (SC) in newly diagnosed, cognitively normal Parkinson’s disease (PD) patients and its relationship with striatal dopaminergic innervation. Background: SC…
  • 2022 International Congress

    Effects of venlafaxine on neuropsychiatric and motor symptoms in patients with progressive supranuclear palsy

    M. Zeitzschel, M. Maheu, T. Donner, C. Gerloff, A. Gulberti, M. Pötter-Nerger (Hamburg, Germany)

    Objective: This prospective, ongoing, interventional trial is related to the ProPSP registry and aims to characterize the effects of venlafaxine, a serotonin-norepinephrine reuptake inhibitor, on…
  • 2022 International Congress

    Impact of botulinum toxin treatment on gait in focal dystonia

    J. Cuinat, B. Debu, P. Pelissier, A. Castrioto, S. Meoni, S. Potel, V. Fraix, E. Moro (Grenoble, France)

    Objective: To study the effects of botulinum neurotoxin (BTX) treatment on gait characteristics in patients with blepharospasm and cervical dystonia. Background: The impact of focal…
  • 2022 International Congress

    The reasons for referral to a Parkinson’s Clinical Psychology service

    R. Lewis-Morton, B. Mohamed, E. Thomas, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To understand the reasons for referral to a Parkinson's Clinical Psychology service. Background: In recent times, the psychological impact of Parkinson’s Disease has become…
  • 2022 International Congress

    Genetic stratification of motor and quality of life outcomes in Parkinson’s disease in the EARLYSTIM study

    D. Weiss, Z. Landoulsi, P. May, M. Sharma, M. Schüpbach, H. You, JC. Corvol, S. Paschen, AK. Helmers, M. Barbe, G. Fink, A. Kühn, C. Brefel-Courbon, L. Wojtecki, P. Damier, V. Fraix, JL. Houeto, J. Regis, F. Sixel-Döring, M. Pinsker, S. Thobois, A. Gharabaghi, V. Stoker, L. Timmermann, A. Schnitzler, P. Krack, M. Vidailhet, G. Deuschl, R. Krüger (Tübingen, Germany)

    Objective: We identified (Weiss et al., 2016) that single nucleotide polymorphism (SNPs) of the alpha-synuclein gene (SNCA) predicted the motor effect of subthalamic nucleus stimulation (STN-DBS)…
  • 2022 International Congress

    Examining the sex differences in the prevalence and incidence of Parkinson disease

    A. Zirra, S. Rao, J. Bestwick, R. Rajalingam, C. Marras, C. Blauwendraat, I. Mata, A. Noyce (London, United Kingdom)

    Objective: The objective of this meta-analysis was to examine the male-to-female (M/F) incidence and prevalence of Parkinson disease. Background: Parkinson disease (PD) is a major…
  • « Previous Page
  • 1
  • …
  • 571
  • 572
  • 573
  • 574
  • 575
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley